Principal Financial Group Inc Macrogenics Inc Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$3.31 - $18.51 $12,637 - $70,671	3,818 Added 1.11%	348,421 $1.48 Million
Q1 2024 Apr 29, 2024	BUY	$9.77 - $21.47 $749,622 - $1.65 Million	76,727 Added 28.64%	344,603 $5.07 Million
Q4 2023 Feb 07, 2024	SELL	$4.48 - $10.11 $34,379 - $77,584	-7,674 Reduced 2.78%	267,876 $2.58 Million
Q3 2023 Nov 02, 2023	BUY	$4.48 - $6.19 $10,460 - $14,453	2,335 Added 0.85%	275,550 $1.28 Million
Q2 2023 Aug 07, 2023	SELL	$4.62 - $7.54 $207 - $339	-45 Reduced 0.02%	273,215 $1.46 Million
Q1 2023 May 09, 2023	BUY	$4.82 - $7.24 $26,413 - $39,675	5,480 Added 2.05%	273,260 $1.96 Million
Q4 2022 Feb 09, 2023	BUY	$3.34 - $6.98 $7,869 - $16,444	2,356 Added 0.89%	267,780 $1.8 Million
Q3 2022 Nov 09, 2022	BUY	$3.01 - $5.22 $10,447 - $18,118	3,471 Added 1.33%	265,424 $918,000
Q2 2022 Aug 10, 2022	SELL	$2.25 - $9.99 $16,472 - $73,136	-7,321 Reduced 2.72%	261,953 $773,000
Q1 2022 May 09, 2022	BUY	$8.12 - $16.9 $81,159 - $168,915	9,995 Added 3.85%	269,274 $2.37 Million
Q4 2021 Feb 09, 2022	BUY	$15.91 - $21.88 $38,836 - $53,409	2,441 Added 0.95%	259,279 $4.16 Million
Q3 2021 Nov 09, 2021	BUY	$19.74 - $28.7 $149,668 - $217,603	7,582 Added 3.04%	256,838 $5.38 Million
Q2 2021 Aug 10, 2021	BUY	$20.49 - $35.63 $292,105 - $507,941	14,256 Added 6.07%	249,256 $6.7 Million
Q1 2021 May 10, 2021	BUY	$18.99 - $33.2 $664,498 - $1.16 Million	34,992 Added 17.5%	235,000 $7.49 Million
Q4 2020 Feb 08, 2021	BUY	$19.41 - $26.0 $204,212 - $273,546	10,521 Added 5.55%	200,008 $4.57 Million
Q3 2020 Nov 06, 2020	BUY	$24.69 - $31.6 $169,891 - $217,439	6,881 Added 3.77%	189,487 $4.77 Million
Q2 2020 Aug 05, 2020	SELL	$5.2 - $29.12 $194,937 - $1.09 Million	-37,488 Reduced 17.03%	182,606 $5.1 Million
Q1 2020 May 12, 2020	SELL	$4.28 - $12.11 $213,280 - $603,465	-49,832 Reduced 18.46%	220,094 $1.28 Million
Q4 2019 Feb 05, 2020	BUY	$7.95 - $12.27 $403,724 - $623,107	50,783 Added 23.17%	269,926 $2.94 Million
Q3 2019 Nov 13, 2019	SELL	$12.44 - $17.48 $195,171 - $274,243	-15,689 Reduced 6.68%	219,143 $2.8 Million
Q2 2019 Aug 12, 2019	BUY	$14.51 - $19.71 $753,823 - $1.02 Million	51,952 Added 28.41%	234,832 $3.99 Million
Q1 2019 May 10, 2019	BUY	$11.11 - $25.6 $269,073 - $620,006	24,219 Added 15.26%	182,880 $3.29 Million
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $5,358 - $9,767	456 Added 0.29%	158,661 $2.02 Million
Q3 2018 Nov 14, 2018	BUY	$19.26 - $23.46 $78,657 - $95,810	4,084 Added 2.65%	158,205 $3.39 Million
Q2 2018 Aug 13, 2018	BUY	$19.78 - $24.67 $1.39 Million - $1.74 Million	70,407 Added 84.1%	154,121 $0
Q1 2018 May 14, 2018	BUY	$18.89 - $32.46 $2,040 - $3,505	108 Added 0.13%	83,714 $2.11 Million
Q4 2017 Feb 13, 2018	SELL	$16.19 - $20.3 $494,102 - $619,535	-30,519 Reduced 26.74%	83,606 $1.59 Million
Q3 2017 Nov 02, 2017	BUY	$15.52 - $18.94 $1.77 Million - $2.16 Million	114,125	114,125 $2.11 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.2 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.3 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.1 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account